ZoomAway and General Genomics Sign Joint Venture for New Product-Shield Score

Author's Avatar
Jun 01, 2020
Article's Main Image

VANCOUVER, BC / ACCESSWIRE / June 1, 2020 / ZoomAway Travel Inc. (TSXV:ZMA, Financial)(OTCQB:ZMWYF) (the "Company" or "ZMA") www.zoomaway.com, a leader in the hospitality technology sector, is pleased to announce that has signed a Joint Venture agreement with General Genomics (www.curo46.com) to partner on the new Shield Score project.